Skip to Content
Uncategorized

How to Motivate Your Monkey

Our September issue reports the discontinuation of the human trials Avigen was conducting on a new hemophilia treatment–the latest of many setbacks in the commercialization of gene therapy. But basic research in the field has continued undaunted, with results that…
August 12, 2004

Our September issue reports the discontinuation of the human trials Avigen was conducting on a new hemophilia treatment–the latest of many setbacks in the commercialization of gene therapy. But basic research in the field has continued undaunted, with results that may strike you as either astounding or terrifying, depending on how you feel about the prospect of genetically modifying your personality.

Researchers at the National Institute of Mental Health have used gene therapy to “cure” monkeys of their tendency to procrastinate. Similar treatments could eventually benefit people suffering from depression, schizophrenia, and obsessive-compulsive disorder; but they could also take the debate about the “medicalization” of psychological characteristics into a whole new arena.

Keep Reading

Most Popular

The inside story of how ChatGPT was built from the people who made it

Exclusive conversations that take us behind the scenes of a cultural phenomenon.

How Rust went from a side project to the world’s most-loved programming language

For decades, coders wrote critical systems in C and C++. Now they turn to Rust.

Design thinking was supposed to fix the world. Where did it go wrong?

An approach that promised to democratize design may have done the opposite.

Sam Altman invested $180 million into a company trying to delay death

Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.